Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/002—Protozoa antigens
  • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines
  • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P33/00—Antiparasitic agents
  • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
  • A61P33/06—Antimalarials
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
  • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
  • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
  • A61K2039/6031—Proteins
  • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
  • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Tropical Medicine & Parasitology (AREA)
• Epidemiology (AREA)
• Immunology (AREA)
• Microbiology (AREA)
• Mycology (AREA)
• Dermatology (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=42337137

Family Applications (1)

Country Status (18)

Families Citing this family (16)

Family Cites Families (26)

• 2010
  • 2010-01-08 SG SG2011049020A patent/SG172856A1/en unknown
  • 2010-01-08 CA CA2749262A patent/CA2749262C/en active Active
  • 2010-01-08 US US12/684,863 patent/US8043625B2/en active Active
  • 2010-01-08 AP AP2011005800A patent/AP3192A/xx active
  • 2010-01-08 ES ES10731974.1T patent/ES2640614T3/es active Active
  • 2010-01-08 SI SI201031539T patent/SI2387416T1/sl unknown
  • 2010-01-08 AU AU2010204887A patent/AU2010204887B2/en not_active Ceased
  • 2010-01-08 PT PT107319741T patent/PT2387416T/pt unknown
  • 2010-01-08 SG SG2014003065A patent/SG196820A1/en unknown
  • 2010-01-08 BR BRPI1006863A patent/BRPI1006863A2/pt not_active IP Right Cessation
  • 2010-01-08 WO PCT/US2010/020564 patent/WO2010083111A1/en not_active Ceased
  • 2010-01-08 EP EP10731974.1A patent/EP2387416B1/en active Active
  • 2010-01-08 CN CN201080004734.7A patent/CN102292103B/zh active Active
  • 2010-01-08 DK DK10731974.1T patent/DK2387416T3/en active
  • 2010-01-08 KR KR1020117018968A patent/KR101764142B1/ko active Active
  • 2010-01-08 JP JP2011546286A patent/JP5738199B2/ja active Active
  • 2010-01-14 TW TW099100939A patent/TWI517858B/zh active
  • 2010-08-27 US US12/870,102 patent/US8367810B2/en active Active
• 2011
  • 2011-07-04 ZA ZA2011/04897A patent/ZA201104897B/en unknown
  • 2011-07-05 IL IL213929A patent/IL213929B/en active IP Right Grant
• 2012
  • 2012-12-28 US US13/730,294 patent/US8821896B2/en active Active
  • 2012-12-28 US US13/730,281 patent/US8992944B2/en active Active
• 2015
  • 2015-03-27 US US14/671,003 patent/US9241982B2/en active Active
• 2016
  • 2016-01-21 US US15/002,443 patent/US9616115B2/en active Active
• 2017
  • 2017-03-14 US US15/458,792 patent/US10272146B2/en active Active

Also Published As

Similar Documents